Recruiting NA Asthma in Children

New treatment option for Asthma in Children

Official title Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English

ClinicalTrials.gov ID: NCT06239844

What this study is testing

What it's testing
The Nav-Team study reviews how well the asthma navigators/coordinator program can improve the lives of asthmatic children, and their caregivers, by providing additional assistance and education. Aim 1 of the study will partner with immigrant serving community organizations to hold meetings that will help tailor the programs.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 4 to 89

You may be able to join if

  • eria for Nav-TEAM Intervention Dyads include:
  • Child aged 4-12 years.
  • Child with persistent asthma (defined by currently prescribed controller medication).
  • Parent/legal guardian who is at least 18 years old.

You likely can't join if

  • for Nav-TEAM Intervention Dyads include:
  • Child aged under 4 and over 12 years of age.
  • Child with no persistent asthma (defined by currently prescribed controller medication).
  • Parent/legal guardian who is under 18 years old.
  • Any parent/legal guardian whose preferred spoken language is English.
  • Child requires additional continuous respiratory support (e.g,. tracheostomy with home ventilation, continuous daytime oxygen).
See the full eligibility criteria
Who can join
  • eria for Nav-TEAM Intervention Dyads include:
  • Child aged 4-12 years.
  • Child with persistent asthma (defined by currently prescribed controller medication).
  • Parent/legal guardian who is at least 18 years old.
What rules you out
  • for Nav-TEAM Intervention Dyads include:
  • Child aged under 4 and over 12 years of age.
  • Child with no persistent asthma (defined by currently prescribed controller medication).
  • Parent/legal guardian who is under 18 years old.
  • Any parent/legal guardian whose preferred spoken language is English.
  • Child requires additional continuous respiratory support (e.g,. tracheostomy with home ventilation, continuous daytime oxygen).
  • Child is enrolled in another study health system associated asthma navigation program (e.g. school or home-visiting programs).
  • Spoken non-English preferred healthcare language of parent/legal guardian.
  • Child does NOT require additional continuous respiratory support (e.g., nighttime use of Continuous positive airway pressure machine for obstructive sleep apnea would be eligible).
  • Child does NOT have a complex medical/genetic condition that affects swallowing or lung function (e.g. g-tube with aspiration, cystic fibrosis)
  • Child is NOT enrolled in another study health system associated asthma navigation program (e.g. school or home-visiting programs).

The study team makes the final eligibility decision.

Where it's taking place

  • Aurora, Colorado, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 4 years to 89 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Aurora, Colorado, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.